首页> 美国卫生研究院文献>Case Reports in Anesthesiology >Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance
【2h】

Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance

机译:右美托咪定作为阿片类药物耐受性强的患者对阿片类药物引起的痛觉过敏的多峰镇痛治疗方案的一部分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute postoperative pain in patients with opioid tolerance creates a significant management challenge for anesthesiologists and pain medicine physicians. A multimodal approach is key; however other factors can complicate management such as opioid induced hyperalgesia. We present the case of a patient on large amounts of intrathecal opioids for chronic pain syndrome with opioid induced hyperalgesia after an exploratory laparotomy. Dexmedetomidine was utilized successfully as part of a controlled multimodal analgesic plan and should be a consideration for opioid tolerant patients experiencing opioid induced hyperalgesia.
机译:阿片耐受性患者的急性术后疼痛给麻醉师和止痛医生带来了重大的管理挑战。多模式方法是关键。但是其他因素也会使管理复杂化,例如阿片类药物引起的痛觉过敏。我们提出了在探查性剖腹手术后大量鞘内使用阿片类药物治疗慢性疼痛综合征伴阿片类药物引起的痛觉过敏的病例。右美托咪定已成功用作可控制的多式联用镇痛计划的一部分,应作为耐受阿片类药物引起的痛觉过敏的患者的考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号